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SltllTlmary 
Recent evidence suggests that T cells expressing y/6 antigen receptors (T cell receptor [TCR]) 
are subject to positive selection during development. We have shown that T  cells expressing 
a class  I major histocompatibility complex (MHC)-specific  "//6 TCR transgene (tg) are not 
positively selected in class I MHC-deficient, B2-microglobulin (B2m) gene knockout mice (tg + 
~82m-).  In  this  report,  we  examine  phenotypic  and  functional  parameters  of y/6  positive 
selection in this transgenic model system. TCR-3'/6 tg + thymocytes of mature surface phenotype 
(heat stable antigen-,  CD5 hi) were found in/~2m + but not in B2m-  mice. Moreover, subsets 
of tg + thymocytes with the phenotype of activated T  cells (interleukin [IL]2R §  CD44 hi, or 
Mel-141~  were also present only in the B2m + mice.  Cyclosporine A,  which blocks positive 
selection of TCR-odB T cells, also inhibited y/6 tg + T cell development. These results support 
the idea that positive selection of TCR-7/6 requires active TCR-mediated signal transduction. 
Whereas tg + O2m + thymocytes produced IL-2 and proliferated when stimulated by alloantigen, 
TCR  engagement  of tg +  lJ2m-  thymocytes by  antigen  induced  ID2R  expression but  was 
uncoupled  from  the  signal  transduction  pathway  leading  to  II.-2  production  and  autocrine 
proliferation. Overall, these results demonstrate significant parallels between y/6 and ot/B lineage 
development, and suggest a general role for TCR signaling in thymic maturation. 
T 
he final stages of T  cell differentiation in the thymus 
are mediated through interactions between the TCR and 
self-ligands consisting of both MHC and non-MHC antigens 
(1, 2). The TCR-self-antigen interactions that lead to clonal 
deletion or inactivation (anergy) are referred to as negative 
selection and serve to maintain self-tolerance. TCR-self-antigen 
interactions also are required for maturation of thymocytes 
into  the  mature phenotypes  that  are  fully functional  and 
capable of exiting from the thymus and establishing the T 
cell  repertoire  of the  peripheral  lymphoid  system.  Thus, 
the differentiation of CD4 + CD8 + thymocytes into CD4 § 
CD8-  or CD4-CD8 § single-positive T cells requires an in- 
teraction of the TCR with appropriate self-class II or -class 
I MHC antigens, respectively, expressed on thymic epithe- 
lial cells.  This process,  termed positive selection,  has been 
illustrated in a number of experimental models, including 
TCR transgenic mice as well as mice that fail to express class 
I or II MHC antigens as a result of gene disruptions through 
homologous recombination (3-10). However, the molecular 
basis of signal transduction during positive selection, as well 
as the manner in which distinct TCR signals can lead alter- 
natively to negative or positive selection in the thymus, are 
poorly understood. 
We have recently established a model system demonstrating 
a requirement for positive selection of thymocytes expressing 
a  class  I  MHC-specific  transgenic  TCR-3,/6  (transgene 
[tg]l).  Tg + mice were bred  to mice expressing no class  I 
MHC because of the disruption of their ~2-microglobulin 
(B2m) gene through  homologous recombination.  The re- 
sulting tg + fl2m-  offspring had tg +  thymocytes that  did 
not proliferate when stimulated through the TCR, and failed 
to exit from the thymus to populate peripheral lymphoid 
organs (11). Given that many non-MHC-specific y/6 T cells 
1 Abbreviations  used in this tm!oer:  132m,/3z-microglobulin; CsA, cyclosporine 
A; HSA, heat stable antigen; tg, transgene. 
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consistent with a maturational block in tg development due 
to the absence of a specific TCR-self-dass I MHC molecule 
interaction, i.e.,  positive selection. 
In an effort to understand the molecular basis of positive 
selection in the "y/5 lineage and to examine its relationship 
to ot/~ T cell differentiation, we have examined various pheno- 
typic and functional characteristics  of the tg §  thymocytes 
from ~2m + versus B2m- mice. Flow cytometric analysis re- 
vealed notable differences in surface antigen expression  be- 
tween these related cell populations, which have allowed us 
to identify the changes in cell surface phenotype associated 
with qr/5 thymocyte maturation. Several markers of pheno- 
typic maturation in the 3'/~ lineage proved to be analogous 
to those denoting ot/B thymocyte  differentiation, suggesting 
that our model could provide insights of general relevance 
for positive selection of the TCR repertoire. 
Materials and Methods 
Animals.  The ~//6 transgenic mice, as well as mice transgenic 
for a TCR-a/~ specific  for pigeon cytochrome c/I-E  k, have been 
previously described (4, 13), as have been the fl2m-deficient  mice 
(7). BALB/c,  C57B1/6, and B10.BR mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME) or from the National Cancer 
Institute-Frederick Animal Research Facility (Frederick, MD). 
Antibodies.  FITC-conjugated  antibodies  used are as follows:  anti- 
V3'2, anti-ot//~ (both from Pharmingen, San Diego, CA), goat 
anti-hamster IgG and goat anti-rat IgG (both from Caltag Labora- 
tories, San Francisco, CA). Biotinylated antibodies included anti-: 
heat stable antigen (HSA), Pgp-1 (CD44), CD45RB (16A), leuko- 
cyte cell adhesion molecule (LECAM) (Mel-14), IL-2R (all from 
Pharmingen), CD4 (Caltag Laboratories),  and CD5 (Becton Dick- 
inson & Co., Mountain View, CA). For fluorescent staining, hy- 
bridoma supernatants of anti-V/~3 (KJ25) (14) and anti-Vcdl (RR8) 
(15) were used followed by the appropriate FITC-conjugated sec- 
ondary antibody. Removal of CD4 + and CD8 + cells from thymic 
preparations used for staining and proliferation assays  by magnetic 
bead separation was performed with hybridoma supernatants of 
GK1.5 and 53-6.72, respectively (American Type Culture Collec- 
tion, Rockville, MD). Anti-CD28 used to stimulate proliferation 
was in the form of ascites (16, 17). Antibodies used for lymphocyte 
depletion of bone marrow ceils used for chimera preparation are 
anti-Thy 1.2 01J) and anti-CD5 (Ly-l.2) (C3PO) (18) in the form 
of hybridoma supernatants. Anti-CD4  (RL172.4) and anti-CD8 
(83-12-5) supernatants (the kind gift of L. A. Jones and A. Kruis- 
beek, Netherlands Cancer Institute) were used with complement 
to prepare thymocytes for the cyclosporine  A (CsA) proliferation 
assay. 
Cell Preparation.  Thymuses were removed from each group of 
mice, pooled, and single cell suspensions made. Populations of 
CD4-CDS-  V3"2  +  thymocytes  were purified by  incubating 
thymic populations with rat IgG antibodies to CD4 (GK1.5) and 
CD8 (53-6.72), followed  by incubation with magnetic beads coated 
with sheep anti-rat lgG (Dynabeads;  Dynal, Inc., Great Neck, NY). 
Cell separation was performed by magnetic removal of CD4 + and 
CD8 + cells bound to the beads. Using  this method,  virtually 
100% of the cells were CD4-CD8-  double negative and on av- 
erage, 85% of the purified cell population was V3/2  +  ￿9 BALB/c, 
CD57B1/6, and B10.BR splenic cells used as APCs were processed 
into a single cell suspension, and RBCs were lysed with ACK lysis 
buffer (Biofluids  Inc., tLockville,  MD). Spleens were irradiated  with 
2,000 rad. Bone marrow cells for generation of chimeras were 
depleted of  mature lymphocytes  by complement-mediated  lysis  with 
anti-Thyl.2 and anti-Ly-l.2 antibodies plus complement. 
Fluorescence Staining and FACS  |  Analysis.  Staining was per- 
formed using standard techniques, Briefly,  0.5-106 cells were first 
incubated with FITC-conjugated antibodies or hybridoma super- 
natants followed  by the appropriate FIq'~E-conjugated  anti-Ig. Cells 
were then incubated with biotinylated  antibodies followed  by strep- 
tavidin conjugated to PE or allophycocyanin  (Cal-biochem-Nova- 
biochem Corp., La  Jolla, CA). In some experiments, ceils  were fixed 
with 1% paraformaldehyde  after staining. Flow cytometric anal- 
ysis was performed using either a FACS  |  (model 440; Becton Dick- 
inson & Co.; see Figs. 4 and 5, experiment 1); an Epics (Coulter 
Electronics Inc., Hialeah, FL; see Figs. 1, 2, and 6); or a FACScan  | 
(Becton Dickinson & Co.; see Fig. 5, experiment 2). FACS  |  anal- 
yses  were performed  either on selected  double negative  (DN) thymo- 
cytes or on whole thymocyte populations, depending on the total 
number of thymocytes available for analysis. However, the results 
obtained using either whole thymocyte  populations or purified  DN 
cells were always qualitatively equivalent. 
Proliferation Assays.  5  x  104 CD4-CD8-  tg + thymocytes per 
well were plated in flat-bottomed microtiter plates in complete 
media. 5  x  105 irradiated spleen cells/well from either BALB/c 
or C57B1/6 mice were used as APCs. Human recombinant IL-2 
(Cetus Corp., Emeryville, CA) was added at a final concentration 
of 50 U/ml. 1 #M ionomycin (Calbiochem-Novabiochem)  and/or 
10 -7 M PMA (Sigma Immunochemicals, St. Louis, MO) were 
added to 5  x  104 thymocytes without APCs. Anti-CD28 anti- 
body was used as a 1:500 dilution of ascites. Assays  were done in 
triplicate and cells were cultured for 48 h at which time 1 IxCi 
of [3H]thymidine  was added. After further incubation for 12-16 h, 
proliferation was  measured as  incorporation  of [3H]thymidine 
in cpm. 
CsA Treatment of Bone Marrow Chimeras.  BALB/c  or B10.BtL 
mice were irradiated (850 rad) using a Cs source at day 0. The 
following day, 0.5-107 lymphocyte-depleted bone marrow cells 
from TCIL-3,/~ (BALB/c)  or TCR-a//~ (B10.BR) transgenic mice 
were injected intravenously into the irradiated recipients. On day 
3, daily intraperitoneal injections of CsA (20 mg/kg) or olive oil 
as a control were begun. After CsA treatment for the amount of 
time indicated in the figure legends, thymuses and spleens were 
removed and evaluated by flow cytometry. 
Results 
Phenotypic Changes Associated with Positive Selection of  7/8 
tg + Thymoqtes.  Studies of TCR-a/fl lineage development 
have shown that T cell maturation in the thymus is accom- 
panied by progressive changes in the expression  of a variety 
of cell surface proteins (19, 20). These observations have been 
useful in purifying distinct subsets of thymocytes and in ex- 
amining their functional properties.  The interactions of these 
cell surface molecules with their ligands may mediate signal 
transduction events important for differentiation or may de- 
termine appropriate call migration, either within the thymus 
or to peripheral lymphoid organs. 
We  performed  flow  cytometric  analysis  to  determine 
whether we could identify phenotypic differences between 
positively sdected -y/~i tg + thymocytes from ~2m + mice and 
nonpositively selected tg + cells from 3zm-  mice.  Analyses 
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on selected CD4-CD8-  (DN) thymocytes. The expression 
patterns of each surface marker shown are representative of 
several independent experiments. 
The HSA is a heavily glycosylated cell surface protein that 
is expressed  at high levels on immature thymocytes and is 
progressively downregulated during thymic maturation, such 
that the most mature thymocytes and peripheral T cells are 
HSA-  (21). Recent studies have shown that HSA serves as 
a maturational marker for ~//~ as well as for c~/~ T cells (12). 
For example, we (unpublished observations) and others (22) 
have found that only HSA- y/~  thymocytes proliferate in 
response to TCR stimulation. Therefore, we examined tg § 
thymocytes from B2m + and ~2m- mice for HSA expression. 
The tg +  thymocytes from B~m +  mice consisted of both 
HSA + and HSA- subsets (Fig.  1). Although the percentage 
of tg +  HSA-  thymocytes was variable  among individual 
~2m + mice, a significant number of tg + HSA-  cells was 
consistently observed.  In contrast, the tg + B2m- thymocyte 
population was reproducibly almost entirely HSA + (Fig. 1), 
consistent with a maturational block resulting from the ab- 
sence of positive selection.  Several other surface markers as- 
sociated with thymic development were also differentially  ex- 
pressed by tg + B~m + versus ~2m- thymocytes. The level of 
CD5 expression also distinguishes immature from mature c~/B 
thymocytes, rising progressively during c~/~ thymic matu- 
ration (23).  Accordingly, we examined CD5 expression  on 
the 3'/b thymocytes, and found that it was expressed at higher 
levels on tg + ~2m + than on tg + ~2m- cells. Mean fluores- 
cence intensity of CD5 was 33.8 on ~2m + thymocytes com- 
pared with 28.4 in/32m-  mice (25% greater expression on 
~2m + thymocytes). It is interesting that unlike o~/~ T cells, 
CD5 expression  is dull on peripheral tg + y/~3 T  cells (data 
not shown). Also, a significant subset of tg § B2m +, but not 
tg +  ~2m-  thymocytes expressed  the  CD45RB  antigen, 
which has recently been shown to be expressed on a subset 
of late  CD4 +  CD8 +  thymocytes expressing  intermediate 
levels of ol/B TCR (24). Using TCR-c~/~ transgenic models, 
intrathymic CD45RB expression  was also recently shown 
to correlate with positive selection in the oL/fl lineage (25). 
We also found differential expression ofceU surface markers 
associated with T cell activation between the tg + B2m § and 
B2m-  thymocyte populations (Fig.  2).  Both II,-2 receptors 
and CD44, which are upregulated after T cell activation (26, 
27), were expressed at high levels on distinct subpopulations 
of tg + fl2m + cells. Three distinct levels of CD44 expression 
(high, intermediate, and low) were observed (Fig.  2). Tg + 
cells expressing the highest level of CD44 (CD44hi), corre- 
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Figure 1.  Surface  phenotype analysis of differentiation  antigens on 
transgene-bearing thymocytes  in ~2m + and B2m- mice. CD4-CDS- 
thymocytes  purified  by magnetic  bead separation  (see  Materials  and Methods) 
were analyzed  by two-color  flow  cytometry  for expression of maturation 
markers on tg + cells. The FACS  |  profiles of the various surface  markers 
shown are taken  from  different  experiments,  but ~2m* and ~2m- profiles 
are from the same experiment for each parameter. The results shown  for 
each surface  marker were verified  in several experiments and were highly 
reproducible. (MFI) mean fluorescence  intensity. 
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Figure  2.  Subsets  of tg § thymocytes  from B2m  + but not B2m- mice 
express a surface  phenotype  characteristic  ofceU  activation.  Two-color  flow 
cytometry  as described  in Fig. 1 was used to compare the surface  expres- 
sion of CD44, IL2R, and Mel-14 on V3~2  + thymocytes  from each group 
of mice. Evaluation  of ll.-2Rol and CD44 expression was performed  on 
whole thymus. Mel-14 expression was examined  on CD4-CD8- thymo- 
cytes purified by magnetic  bead separation. 
1063  Wells et al. sponding to the level of CD44 expression seen after activa- 
tion of mature T  cells (26)  (see Fig.  6) constituted 8%  of 
total thymocytes in the ~2m + mice in the experiment shown 
(Fig.  2).  The Ib2R + and CD44 hi populations were found 
to be distinct by virtue of the fact that all the IL-2R + cells 
were HSA + , whereas the CD44 hi cells were found predom- 
inantly among the more mature HSA-  thymocytes (data 
not shown). In addition, a subset of tg +/82m + thymocytes 
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Figure  3.  Inhibition of antigen induced proliferation of oz//3 and T/~ 
transgenic thymocytes by CsA. Purified tg + thymocytes were cultured 
in the presence of antigen and various  concentrations of CsA. Prolifera- 
tion was  measured as incorporation of [3H]thymidine as described  in 
Materials and Methods.  (A) 105 purified cytochrome c-specific CD4 + a/~ 
tg +  thymocytes (obtained by incubation with anti-CD8 antibody and 
complement) were cultured with 5  x  105 syngeneic H-2  k B10.BR. APCs, 
2.5 ~M cytochrome c, and various concentrations of CsA. Proliferation 
of tg* cells to syngeneic APC alone was 335 cpm. (B) 2.5  x  104 .,//8 
tg + thymocytes were cultured with 5  x  105 allogeneic  H-2  b APCs and 
various concentrations of CsA. cpm with syngeneic H-2  a BALB/c APCs 
were 159. 
were Met-141~ Mel-14,  the lymph node-specific L-selectin 
homing receptor, is also transiently downregulated after T 
cell activation (28, 29).  In contrast with the expression pat- 
tern of these cell  surface molecules on tg + /~2m  + thymo- 
cytes, there were few tg + B2m-  thymocytes that were ei- 
ther  Ib2R +,  CD44 hi,  or  Mr-14 ~ (Fig.  2).  However,  a 
variable percentage of tg + ~2m-  thymocytes were CD44 int 
(see Fig.  6).  The fact that differential ID2R expression be- 
tween tg + B2m + and tg + ~/2m-  ceils is already observed 
within the HSA + population suggests that the TCR inter- 
actions leading to positive selection of y/8 cells may begin 
at a relatively early stage of differentiation. Moreover, the 
activated phenotype observed during thymic selection is tran- 
sient, as tg ~ cells in peripheral lymphoid organs are Ib2R-, 
CD44 ~  and Mr-14  hi (data not shown). 
y/t~ Thymocyte Development  Is Influenced by CsA.  Although 
the signals that mediate positive selection of TCR-o~/B thymo- 
cytes are ill-defined, it is known that the process is sensitive 
to the inhibitory effects of CsA. For example, experiments 
in which CsA was administered to mice after irradiation and 
bone marrow reconstitution have shown that c~//3 thymo- 
cyte development is blocked at the CD4+CD8 + stage,  be- 
fore the selection of mature single-positive thymocytes 00-32). 
In  contrast,  these  studies  showed that  the appearance of 
TCR-y/t~-bearing CD4-CD8-  thymocytes was apparently 
unaffected by CsA, and therefore it was suggested that "y/~ 
development might not require positive selection. 
However, in view of our evidence for positive selection 
in the 3'/t3 lineage, we decided to investigate further the poten- 
tial effect of CsA on y/8 development. Initially, we exam- 
ined whether the antigen-induced proliferation of y/t~ tg * 
thymocytes was inhibited by CsA. The proliferative response 
of purified y/(5  tg + CD4-CD8-  thymocytes to  antigen 
(H-2  b APCs) was assessed in the presence of various concen- 
trations of CsA (Fig. 3) in direct comparison with the inhi- 
bition by CsA of the antigen-induced proliferation response 
of CD4 +  o~/~  tg +  thymocytes specific  for pigeon  cyto- 
chrome c/I-E  k (4).  As shown, the antigen-specific prolifer- 
ation of both 3,//i and a/:/transgenic  thymocytes was in- 
hibited at identical concentrations of CsA (Fig. 3). Thus, signal 
transduction through the y/t~ tg is sensitive to CsA. 
To readdress the issue of CsA and y/t~ T cell differentiation, 
we reconstituted irradiated BALB/c mice with lymphocyte- 
depleted y/8 tg + bone marrow, and examined thymocyte 
development in CsA-treated and control animals, according 
to previous protocols (31, 32). Flow cytometric analysis was 
performed on thymocyte populations  3--4 wk  after bone 
marrow reconstitution. CD4 or CD8 single-positive TCR- 
c~/~/thymocytes, observed in the control mice, were absent 
in the animals that had been treated with daily intraperitoneal 
injections of CsA (Fig. 4 A). In contrast, there were abun- 
dant TCR-y/8  tg + CD4-CD8-  cells,  expressing normal 
levels of TCR, in both CsA-treated and control animals.  To 
rule out the possibility that this result could be attributed 
simply to  the inability  of CsA  to  inhibit  maturation  of 
tg-bearing thymocytes, we reconstituted irradiated B10.BR 
animals with bone marrow from mice expressing a class II 
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Figure  4.  Effect  of CsA on development of "y/(~ and ol/B transgene- 
bearing cells. Irradiated mice were reconstituted with lymphocyte-depleted 
bone marrow from "y/~ and c~/~ transgenic mice and then treated with 
CsA (20 mg/kg/d) or olive oil for 21 d. Thymocytes from these mice were 
then removed and examined for expression of the transgenic TCRs. (A) 
Lethally irradiated BALB/c (H-2  d) mice were reconstituted with bone 
marrow cells from mice expressing the 3~//~ tg. After 21 d ofintraperitoneal 
treatment with CsA or olive  oil alone, thymocytes  were removed  and double- 
stained with anti-V3~2 or anti-TCR-od/~ and anti-CD4 mAbs. (B) Bone 
marrow cells from mice expressing a class II MHC (I-E  k) restricted pi- 
geon cytochrome c-specific  TCR-cdB tg were used to reconstitute lethally 
irradiated B10.BR mice. They then received  daily intraperitoneal CsA or 
olive oil alone as above. Thymocytes were examined by two-color flow 
cytometry for expression of Vc~11 or VB3 and CD4. 
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Figure  5.  Effect  of CsA on cell surface phenotype of TCR.-3,/~ tg + 
thymocytes and on expression of the tg in peripheral lymphoid organs 
(spleen). Bone marrow reconstitution experiments were conducted as de- 
scribed in Fig. 4 and Materials and Methods using a CsA dose of 20 
mg/kg/d. Thymocytes and spleen cells were evaluated after 4 wk (EXl~ 
I) or 8 wk (Exl~ 2) by two-color flow cytometry for the surface  expression 
of V3'2 and HSA molecules. 
MHC-restricted pigeon cytochrome c-specific TCR-cZ~ tg 
and examined  the effect of CsA treatment  on the develop- 
ment of (~//~ tg-bearing thymocytes (Fig. 4 B). As observed 
for nontransgenic TCR-odB T  cells (Fig. 4 A) (30-32), CsA 
treatment completely blocked the differentiation of o~/B tg + 
thymocytes  to the  mature  CD4+CD8 -  phenotype.  Thus, 
we conclude  that  CsA  specifically does not  inhibit  the  in- 
trathymic appearance of CD4-CDS-  cells expressing nor- 
mal levels of the  TCR-'y/~ tg. 
However, further analysis did show evidence of an inhibi- 
tory effect of CsA on 3~/(5 development  (Fig.  5).  Whereas 
a  significant  proportion  of the  tg +  cells  from  the  control 
thymuses of bone marrow-reconstituted  mice were HSA-, 
almost all the tg + thymocytes from CsA-treated litter mates 
were  HSA +  (Fig.  5).  Thus,  the  percentage  of "y/t~  HSA- 
tg + thymocytes was markedly reduced in mice treated with 
CsA after bone marrow reconstitution as compared with con- 
trols. It is interesting that a higher percentage of tg + HSA- 
thymocytes was observed in the thymuses of bone marrow- 
transplanted mice examined 8 wk after reconstitution  (Fig. 
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Figure  6.  Tg-bearing  thymocytes  from  both 32m + and 32m- mice  in- 
crease surface expression of IL-2R and CD44 after exposure to antigen. 
CD4-CD8-  tg + thymocytes  purified  by magnetic  bead separation from 
/~2m  + or B2m- mice were stimulated  for 48-72 h with antigen (H-2b 
splenic APCs) and then evaluated  by two-color flow cytometry  for the 
expression of ID2R or CD44 on Vy2  + cells. Unstimulated  cells were ex- 
amined by flow  cytometry  either after incubation  for 48-72 h with syn- 
geneic (H-2  d) APCs (IL2R); or before any culture (CD44). In the ex- 
periment evaluating  CD44 upregulation, tg-bearing cells were cultured 
in the presence  of rib2 (50 U/ml) in addition  to antigen. No upregulation 
of CD44 was observed with IL-2 alone (data not shown). 
5, exp. 2) as compared with 4 wk after reconstitution (Fig. 
5, exp.  1). We have consistently observed  that the propor- 
tion of HSA-  tg + thymocytes increases with time after ir- 
radiation and bone marrow reconstitution.  Although the 
reason for this is unclear, the observation is highly reproduc- 
ible (Tatsumi, Y., J. Pena, L. Matis, D. DeLuca, and J. Blue- 
stone, manuscript submitted for publication).  Also, CsA treat- 
ment markedly reduced the number of tg-bearing cells in 
the peripheral lymphoid organs (Fig. 5, exp. 2). Overall, these 
results suggest that the differentiation induced by TCR-3~/6 
interactions with a 32m-assodated self-antigen may indeed 
be inhibited by CsA, and therefore that, as for a/3 develop- 
ment, positive selection of at least some 3'/t~ T cells is CsA 
sensitive. 
Uncoupling of TCR-mediated Signals in 7/8 tg + Thymocytes 
from fl2m-  Mice.  To explore the functional defect in the 
tg + fl2m-  thymocytes, we examined purified populations 
of tg-bearing DN  cells  activated by  various  specific  and 
nonspecific  stimuli. First, we examined surface phenotypic 
changes induced by antigen stimulation. We found that al- 
though, as previously reported (11), the tg + ~2m-  thymo- 
cytes do not proliferate when stimulated by antigen, the an- 
tigen stimulation of these cells did induce upregulation of 
IL-2Rol and CD44 (Fig. 6). Therefore, some components of 
TCR-mediated signal transduction are intact in these cells. 
It should be noted that the IL-2R expression  observed  on 
freshly isolated tg + thymocytes is absent after 2 d of in vitro 
culture in the absence of stimulation (Fig. 6). However, we 
do not believe that the IL-2R expression  seen on the thymo- 
cytes stimulated with antigen (H-2  b APCs) simply reflects 
a lack of IL-2R downregulation. First, IL-2R was also up- 
regulated after antigen stimulation of the tg + 32m- thymo- 
cytes (Fig. 6), a population which initially does not express 
any IL-2R (Fig.  2). Second,  we have evidence that IL-2R is 
upregulated after antigen stimulation of purified HSA- tg + 
thymocytes, cells that do not express IL-2Rc~ (data not shown). 
We next assessed the ability of the tg-bearing populations 
to proliferate in response  to mitogenic stimuli. In concert 
with the ability of the tg § 32m-  cells to upregulate Ib21k 
after antigen stimulation, the addition of exogenous IL-2 to 
antigen-stimulated cultures induced a strong proliferative re- 
sponse (Table 1). Thus, the IL-2-IL-2R signaling pathway is 
intact in these cells. A subpopulation of thymocytes present 
in 32m + mice proliferated in response  to exogenous IL-2 
alone (Table 1).  We presume but have not shown directly 
that these represent  the tg §  HSA + ID2R + cells (Fig.  2). 
Few IL-2R + cells are present in tg + 32m-  thymuses and, 
accordingly, they manifested little proliferative response to IL-2. 
The significance of the HSA + IL-2R + phenotype in ~//6 
tg development has not been established,  and no clearly ap- 
parent homologous population has been identified in the o~/3 
lineage, where the role of II~2-IL-2R interactions during 
thymopoiesis  remains  controversial  (33,  34).  In  normal 
thymuses, IL-2Rct is transiently expressed on a small popula- 
Table  1.  Effect  of It.-2  on Vrot~fer, nio,,  of .r/,~  tg +  Thy,,,ocyte, 
No  IL-2  IL-2 
3zm-  32m +  32m-  3zm* 
~m 
APCs 
H-2  a  286  76  3,356  25,287 
H-2  b  790  85,705  40,138  145,512 
Response of tg + thymocytes  of 32m + and 32m- mice to exogenous 
IL-2. 5 x  104 CD4-CD8-  thymocytes  from ~2m + or 32m- 3'/8 tg § 
mice were incubated  with syngeneic  (H-2  d) or allogeneic  (H-2~) APCs. 
Recombinant human IL-2 was added at a concentration  of 50 U/ml. 
Results are reported in  uptake of 3H  in  cpm. This experiment is 
representative of seven different  experiments. 
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nificant capacity for thymus (e.g., all T cell lineages) recon- 
stitution (35). Normally, IL-2R cannot be detected on more 
mature TCR + thymocytes (35, 36).  However, IL-2R expres- 
sion has also previously been observed at low levels on TCR- 
c~//3 tg + thymocytes (37). Thus, it cannot be ruled out that 
IL-2R expression on TCR + thymocytes will be a pheno- 
menon associated exclusively with transgenic mouse models, 
perhaps related to the accelerated TCR expression during 
thymic differentiation seen in these animals. However, an in- 
triguing model system was recently described in which an 
immature CD4 +  CD8 + TCR-ot//3 tg-expressing T cell line 
could be induced to differentiate in vitro to a CD4 +  CDS- 
phenotype in the presence of cognate antigen and MHC (38). 
Among the phenotypic changes accompanying the apparent 
in vitro positive selection of this cell line were the upregula- 
tion of CD69, CD44, and CD25 (IL-21kot). Thus, it remains 
of interest to determine whether IL-2 plays a critical role in 
T  cell maturation. 
To bypass  the requirement for TCR-mediated signaling, 
tg § populations were activated with ionomycin and PMA. 
Under these conditions, the tg §  thymocytes showed 
significant, but reduced proliferation in comparison with their 
/32m +  counterparts  (Table  2).  We  also  studied  signaling 
through the T  cell costimulatory molecule CD28 (39-43). 
The expression of CD28 on developing thymocytes, the pres- 
ence of the CD28 ligand B7 on thymic stromal cells,  and 
the ability of thymocytes to be activated through the CD28 
signaling pathway, all have implicated CD28 as having a role 
in thymic development. Using a murine CD28-specific mAb 
(16,  17) we determined that CD28 was expressed on both 
tg + 32m + and Bzm- thymocytes (data not shown). Further- 
more, stimulation with the CD28-specific mAb was syner- 
gistic with ionomycin and PMA in augmenting the prolifer- 
ation of both populations (Table 2). This result indicated that 
Table  2.  Activation of ~//r  tg + Thymocytes 
Stimulation  Tg +  32m +  Tg +/32m- 
Ionomycin  77  498 
PMA  103  407 
Ionomycin plus PMA  26,041  6,462 
Ionomycin plus PMA plus CD28  45,724  18,195 
Antigen (H-2  b APCs)  32,262  1,404 
Antigen plus CD28  83,120  1,515 
PMA plus CD28  23,713  19,948 
Antigen plus PMA plus CD28  254,985  17,885 
Antigen plus PMA  15,135  734 
Proliferative  response  of tg + thymocytes  from  32m-  and ~2m + mice  to 
various stimuli. Assays were performed as described  in Table 1 and in 
Materials and Methods to evaluate the response of CD4-CD8-  tg + 
thymocytes  from each type of mouse to mitogenic  stimuli. Experiments 
using PMA plus CD28 as stimuli were done in the presence  of syngeneic 
(H-2  d) APCs. 
the  CD28  signaling  pathway was  functional in  the  tg + 
32m-  thymocytes. In contrast with the effect of CD28 on 
ionomycin plus PMA activation, costimulation with CD28 
mAb enhanced the antigen-induced proliferative response only 
in the tg + 32m + thymic population (Table 2). No increase 
over background was observed when tg § 32m- thymocytes 
were activated by antigen plus CD28-specific mAb. Finally, 
a previously reported mitogenic pathway induced by costimu- 
lation with CD28 and PMA (41) was also found to be func- 
tional in both the tg + /32m  + and 32m-  thymocytes (Table 
2). However, whereas PMA plus CD28 together were strongly 
synergistic with antigen-induced proliferation in the 32m + 
population, the addition of antigen produced no augmenta- 
tion of the CD28 plus PMA-induced proliferation of tg + 
32m-  thymocytes. 
Thus, "),/6 tg + thymocytes that have not undergone posi- 
tive  selection have  a  profound  defect in  coupling  TCR- 
mediated signals to autocrine proliferation pathways. How- 
ever, TCR signaling leading to upregulation of the IL-2R 
is intact, as is the costimulatory pathway transduced through 
the CD28 molecule and the ability to respond to exogenous 
II.-2 after IL-2R upregulation. 
Discussion 
We have determined phenotypic and functional parameters 
that characterize the positive selection of thymocytes expressing 
a class I MHC-specific TCR-3,//t transgene. Our data illus- 
trate that the TCR-self-antigen interactions that occur during 
q///~ positive selection induce demonstrable alterations in cell 
surface phenotype, and are required for the development of 
functionally mature IL-2-producing TCR-3~//~ T  cells. 
There are significant differences between ot/[3  and 3'/6 
differentiation. For example, signaling through the CD4 and 
CD8 molecules, which plays a critical role in ot/3  thymo- 
cyte selection (7-10, 44), appears to have no role in 3'/c5 de- 
velopment. However, the results presented here provide evi- 
dence for at least some common mechanisms underlying both 
ot/3 and 3'/~ differentiation. Thus, some of the phenotypic 
changes that accompany thymocyte maturation are shared by 
cells of the ot/[3 and "y//~ lineages.  It is notable that,  as is 
the case for or/3 T cells, the HSA molecule serves as a marker 
for "g//~ intrathymic development, such that only the HSA- 
TCtL-3~/~5 thymocytes are functionally mature and can exit 
from the thymus to populate peripheral lymphoid tissue (12). 
Accordingly, in the 3~/~ tg § B2m-  mice, differentiation of 
tg-bearing thymocytes is arrested at the HSA + stage. In this 
light, we have also found that the recombination activating 
genes RAG-1 and RAG-2 are expressed in the HSA + TCR- 
3'/c5 tg + thymocytes, but not in HSA- 3'/r  tg + thymocytes 
(Tatsumi, Y. et al.,  manuscript submitted for publication), 
consistent with recent studies showing that RAG gene down- 
regulation correlates with positive selection during ot/[3 de- 
velopment (45, 46). Thus, downregulation of RAG gene ex- 
pression may result from TCR-self-antigen interactions in 
both the or//3 and 3,/6 cell lineages.  Furthermore, the pat- 
terns of expression of other cell surface molecules such as CD5, 
CD44,  CD45,  and Mel-14 also appear to have similarities 
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we have shown that CsA can inhibit the development of the 
3'/+  as well as the c~/~ lineage. 
The  nature  of the  TCR-mediated  signal  transduction 
pathways induced during positive selection remains to be de- 
termined, but indirect evidence suggests that they may have 
some similarities to the signal transduction involved in ma- 
ture T  cell activation. Thus, both mature T  cell activation 
and positive selection are inhibited by CsA (30-32, 47). Re- 
cent insights into the mechanism of immunosuppression by 
CsA have shown that the CsA-cyclophilin complex binds and 
inhibits the Ca +  -dependent phosphatase calcineurin (48-50) 
implying a critical role for this enzyme in the signal trans- 
duction pathway for IL-2 production. It will be interesting 
to determine whether this pathway is induced during thymic 
selection. Also, the kk kinase, whose function is critical for 
signal transduction in mature T  lymphocytes (51),  appears 
to have a central role in mediating c~/B T cell differentiation 
(52). Further studies will examine if lck kinase activity is im- 
portant for ~//6 T  cell development. 
It is interesting that several of the surface phenotypic changes 
associated with positive selection in our system (e.g., expres- 
sion of IL-2R and CD44, downregulation of Mel-14) are char- 
acteristic of changes in phenotype that accompany activation 
of mature T  ceils (25-29).  Similar observations have been 
made by Bendelac and co-workers (53, 54) in an examination 
of the activation events occurring during TCIL-cff~ thymic 
maturation. For example, these investigators identified a sub- 
population of c~/B lineage thymocytes at a late maturational 
stage (HSA-) that expressed high levels of CD44. Based on 
the expression of other surface markers of activation, as well 
as the patterns of lymphokine secretion by discrete thymo- 
cyte subsets,  Bendelac et at. (54) concluded that positive se- 
lection represents a transient but reversible  TCR-mediated 
activation process that provides critical signals  required for 
maturation. 
The functional significance of all the phenotypic changes 
that accompany T cell development are presently unknown. 
Because several of the surface markers (CD45,  HSA,  and 
CD44)  have been shown to have costimulatory properties 
(55-59),  it is possible  that in development they transduce 
signals important for differentiation. In addition, the homing 
receptor functions of molecules such as the L-selectins (Mel-14) 
and CD44 suggest a possible  role in mediating intrathymic 
or extrathymic migration. 
The signal transduction defect in the tg + ~2m-  thymo- 
cytes is characterized by an uncoupling of TCR signaling from 
the pathway leading to IL-2 production. This is a rather selec- 
tive defect in that these cells can upregulate Ib2R when en- 
gaged by antigen and then proliferate in response to exoge- 
nous Ib2. They can also proliferate when TCR signaling is 
bypassed with ionomycin and PMA, although an additional 
defect is implied by the reduced magnitude of this prolifera- 
tive response (Table 2). The functional properties of the tg + 
B2m-  thymocytes are most closely related to those of a re- 
cently identified subset of routine HSA + TCR cUB single- 
positive thymocytes (53,  54),  rather than the more imma- 
ture CD4 +  CD8 + thymocytes that predominate when ot/B 
positive selection is blocked. Murine CD4 +  CD8 + thymo- 
cytes activated through their TCR do not upregulate Ih-2R 
nor respond to exogenous IL-2, although they do flux cal- 
cium (60-64). This could represent a difference in the mo- 
lecular pathways governing positive selection of o~/B versus 
",//+ T  cells.  However, it has also been shown that human 
CD4+CD8 +  thymocytes, like our  tg +  B2m-  HSA + 'y/+ 
thymocytes, can upregulate Ib2R and proliferate to IL-2 after 
TCR engagement (42).  In any event, the selective defect in 
TCR signal transduction resulting from the blockade in 3'/+ 
tg development in the/$2m- environment should provide a 
useful model for dissecting the complex pathway leading to 
II.,2 gene expression after TCR engagement (65). 
In summary, we have demonstrated directly by a variety 
of parameters that 'y/+ T cells can be subject to positive se- 
lection in development. By virtue of the alterations of cell 
surface phenotype, the functional immaturity, and the ab- 
sence of peripheral tg-bearing T cells in B2m- mice, as well 
as the sensitivity of'y/+ tg development to CsA, 3r/+ lineage 
selection parallels that of ot/B T cells in several fundamental 
ways. Moreover, examining a class I MHC TL-specific 3~/+ 
tg in a model system analogous to ours, others have obtained 
very similar results (22).  However, it is also true that sub- 
stantial normal 'y/+ T cell development occurs in nontrans- 
genic B2m- mice (12). Thus, it will be important to deter- 
mine if other 'y/+ T cells undergo positive selection, especially 
non-MHC-specific 3'/+ T  cells, and consequently to estab- 
lish whether TCR-self-antigen interactions represent a crit- 
ical step in all T  cell differentiation. 
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